The Patent Finder

Stallergenes

Also on record
Records under this name other than the patents Stallergenes holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Showing 1 to 4 of 4 · Back to Stallergenes

PatentTitleStatus Expires Confidence
US 7,285,650Cloning and sequencing of the allergen Dac g5 of Dactylis glomerata pollen, its preparation and its use
Term ended
Term ended Nov 12, 2022 · From the USPTO record
Term endedTerm ended Nov 12, 2022From the USPTO record
US 9,822,185Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa
Lapsed on the fee record
Ended Nov 21, 2021 · From the USPTO record
Lapsed on the fee recordEnded Nov 21, 2021From the USPTO record
US 9,480,748Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
Lapsed on the fee record
Ended Nov 1, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 1, 2020From the USPTO record
US 9,187,568Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route
Lapsed on the fee record
Ended Nov 17, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 17, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited